EPSTEIN BARR VIRUS INFECTION
Clinical trials for EPSTEIN BARR VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN BARR VIRUS INFECTION trials appear
Sign up with your email to follow new studies for EPSTEIN BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New EBV vaccines enter human safety trials
⭐️ VACCINE ⭐️ Recruiting nowThis study tests two experimental vaccines against Epstein-Barr virus (EBV), which causes mono and is linked to cancers. Researchers will give 750 healthy adults aged 18-29 three shots over several months to check for side effects and immune response. The goal is to find a safe v…
Matched conditions: EPSTEIN BARR VIRUS INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:34 UTC
-
Can 'Supercharged' donor cells beat viruses that drugs Can't?
Disease control Recruiting nowThis study tests whether giving patients special donor immune cells (called CD45RA-depleted DLI) can treat viral infections that persist after a stem cell transplant. The trial involves 30 participants who have not improved with standard antiviral drugs. Researchers will measure …
Matched conditions: EPSTEIN BARR VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Donor immune cells take on tough viruses in transplant patients
Disease control Recruiting nowThis early-stage trial tests whether specially grown immune cells from a donor can safely help transplant patients fight off viral infections that standard treatments can't control. The cells target Epstein-Barr virus, cytomegalovirus, adenovirus, and BK virus. Up to 36 adults wh…
Matched conditions: EPSTEIN BARR VIRUS INFECTION
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New immune cell therapy takes on virus after transplant
Disease control Recruiting nowThis early-phase study tests a new treatment for Epstein-Barr virus (EBV) that can occur after a stem cell transplant. The treatment uses specially engineered immune cells (EBV-TCR-T cells) to find and destroy virus-infected cells. Up to 18 adult patients who have persistent EBV …
Matched conditions: EPSTEIN BARR VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Why do some teens stay fatigued after mono? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at why some teenagers and young adults feel tired for months after getting Epstein-Barr virus (the virus that causes mono). Researchers will follow 150 infected people and 150 healthy people for six months, using brain scans, immune tests, and questionnaires. The…
Matched conditions: EPSTEIN BARR VIRUS INFECTION
Sponsor: University Hospital, Akershus • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC